-
1دورية أكاديمية
المؤلفون: Sabine Felser, Julia Rogahn, Philipp le Coutre, Haifa Kathrin Al-Ali, Susann Schulze, Lars-Olof Muegge, Julia Gruen, Jan Geissler, Veronika Kraze-Kliebhahn, Christian Junghanss
المصدر: Frontiers in Oncology, Vol 12 (2023)
مصطلحات موضوعية: anxieties, education, fatigue, fears, health-related quality of life (HrQoL), myeloproliferative neoplasms (MPN), Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2022.1056786/fullTest; https://doaj.org/toc/2234-943XTest
-
2
المؤلفون: Sabine Felser (14291308), Julia Rogahn (14326863), Philipp le Coutre (11498449), Haifa Kathrin Al-Ali (13810360), Susann Schulze (14291320), Lars-Olof Muegge (14291323), Julia Gruen (14291314), Jan Geissler (8902553), Veronika Kraze-Kliebhahn (14326866), Christian Junghanss (719129)
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, anxieties, education, fatigue, fears, health-related quality of life (HrQoL), myeloproliferative neoplasms (MPN), physical activity, sports
-
3
المؤلفون: Arlene Reisman, Bfore Study Investigators, Valentín García-Gutiérrez, Charles Chuah, Carlo Gambacorti-Passerini, Andreas Hochhaus, Michael W. Deininger, Dragana Milojkovic, Rocco J. Crescenzo, Tim H. Brümmendorf, Philipp le Coutre, Carla Mamolo, Jorge E. Cortes, Dong-Wook Kim, Michael J. Mauro
المساهمون: Cortes, J, Gambacorti-Passerini, C, Deininger, M, Mauro, M, Chuah, C, Kim, D, Milojkovic, D, le Coutre, P, Garcia-Gutierrez, V, Crescenzo, R, Mamolo, C, Reisman, A, Hochhaus, A, Brummendorf, T
المصدر: Journal of cancer research and clinical oncology. 145(6)
مصطلحات موضوعية: 0301 basic medicine, Cancer Research, medicine.medical_specialty, Health-related quality of life, Population, Newly diagnosed, Drug Administration Schedule, 03 medical and health sciences, 0302 clinical medicine, Quality of life, hemic and lymphatic diseases, Internal medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Surveys and Questionnaires, Nitriles, Medicine, Humans, Patient Reported Outcome Measures, education, Patient-reported outcome, education.field_of_study, Hematology, Aniline Compounds, business.industry, Chronic myeloid leukemia, Cancer, Imatinib, General Medicine, Chronic phase chronic myeloid leukemia, medicine.disease, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Leukemia, Myeloid, Chronic-Phase, Imatinib Mesylate, Quality of Life, Quinolines, Bosutinib, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e16f05ee7c729b1643915c6e699c795Test
https://pubmed.ncbi.nlm.nih.gov/30989330Test -
4
المؤلفون: Michael W. Deininger, Carlo Gambacorti-Passerini, Stephanie Lustgarten, Hagop M. Kantarjian, Martin Müller, Jorge E. Cortes, Delphine Rea, Michele Baccarani, Timothy P. Hughes, Dong-Wook Kim, Ronald Paquette, Daniel J. DeAngelo, Victor M. Rivera, Philipp le Coutre, Neil P. Shah, Charles Chuah, Elisabetta Abruzzese, Javier Pinilla-Ibarz, Franck E. Nicolini, Frank G. Haluska, François Guilhot, Jane F. Apperley, H. Jean Khoury, Moshe Talpaz, Andreas Hochhaus
المساهمون: Cortes, J, Kim, D, Pinilla-Ibarz, J, le Coutre, P, Paquette, R, Chuah, C, Nicolini, F, Apperley, J, Khoury, H, Talpaz, M, Deangelo, D, Abruzzese, E, Rea, D, Baccarani, M, Müller, M, Gambacorti-Passerini, C, Lustgarten, S, Rivera, V, Haluska, F, Guilhot, F, Deininger, M, Hochhaus, A, Hughes, T, Shah, N, Kantarjian, H
مصطلحات موضوعية: Male, Time Factors, Clinical Trials and Observations, NILOTINIB, Biochemistry, RECOMMENDATIONS, chemistry.chemical_compound, 0302 clinical medicine, MED/15 - MALATTIE DEL SANGUE, hemic and lymphatic diseases, 1114 Paediatrics And Reproductive Medicine, Cumulative incidence, Philadelphia Chromosome, IMATINIB-RESISTANT, BCR-ABL, Philadelphia chromosome positive, Aged, 80 and over, education.field_of_study, DASATINIB, Ponatinib, CHRONIC MYELOGENOUS LEUKEMIA, Imidazoles, Hematology, Middle Aged, Prognosis, Dasatinib, Pyridazines, Survival Rate, 030220 oncology & carcinogenesis, Female, Safety, TYROSINE KINASE INHIBITOR, Life Sciences & Biomedicine, medicine.drug, Adult, medicine.medical_specialty, Population, Immunology, Antineoplastic Agents, acute lymphoblastic leukemia, Philadelphia chromosome, 1102 Cardiovascular Medicine And Haematology, CML PATIENTS, 03 medical and health sciences, Young Adult, chronic myeloid leukemia, Internal medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, BCR-ABL INHIBITOR, medicine, Humans, Adverse effect, education, CHRONIC MYELOID-LEUKEMIA, Survival rate, Aged, Salvage Therapy, Science & Technology, business.industry, 1103 Clinical Sciences, Cell Biology, medicine.disease, chemistry, Nilotinib, Drug Resistance, Neoplasm, ADVERSE EVENTS, business, 030215 immunology, Follow-Up Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ffe1d242e2941b0245f32c4df45b7e7Test
http://hdl.handle.net/10044/1/62990Test -
5
المؤلفون: Pilar Giraldo, Bayane Tannir, Cornelius F. Waller, Pia Raanani, Jagannath Ghosh, Philippe Schafhausen, Haifa Kathrin Al-Ali, Renato Tavares, Alessandro M. Vannucchi, Julian Perez Ronco, Vikas Gupta, Bruno Martino, Martin Griesshammer, Philipp le Coutre, Lynda Foltz, Anna Marina Liberati
مصطلحات موضوعية: Male, Ruxolitinib, ruxolitinib, Myelofibrosis, 600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit, Hemoglobins, 0302 clinical medicine, Young adult, Aged, 80 and over, education.field_of_study, Expanded Access Study, Articles, Hematology, Middle Aged, Phenotype, Treatment Outcome, 030220 oncology & carcinogenesis, Retreatment, Female, phase 3b, safety, medicine.drug, Adult, medicine.medical_specialty, Adolescent, Anemia, Population, Young Adult, 03 medical and health sciences, Internal medicine, Nitriles, medicine, Humans, education, Adverse effect, Protein Kinase Inhibitors, Aged, Janus Kinases, Platelet Count, business.industry, medicine.disease, Surgery, Clinical trial, Pyrimidines, Primary Myelofibrosis, Quality of Life, Pyrazoles, business, Biomarkers, Spleen, 030215 immunology
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7b6ac6127c00ebacfa03c9e5175d9bbTest
https://doi.org/10.3324/haematol.2016.143677Test -
6
المؤلفون: José Salvador Rodrigues de Oliveira, Philipp le Coutre, Zhi Xiang Shen, Israel Bendit, Xiaojun Huang, Sadhvi Khanna, Kudrat Abdulkadyrov, Sandip Shah, Eduardo Bullorsky, Manuel Ayala, Rafik Fellague-Chebra, Tina Owugah, Carmino Antonio De Souza, Tomasz Szczudlo, Zhizhou Liang, Jose Luis Lopez, Jorge E. Cortes, Tomasz Sacha, K Govind Babu
مصطلحات موضوعية: Male, Comparative Effectiveness Research, Myeloid, Biomarkers, Pharmacological, Random Allocation, 0302 clinical medicine, Bone Marrow, hemic and lymphatic diseases, Clinical endpoint, Philadelphia Chromosome, Treatment Failure, education.field_of_study, Headache, Hematology, Middle Aged, Europe, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Cytogenetic Analysis, Leukemia, Myeloid, Chronic-Phase, Disease Progression, Imatinib Mesylate, Female, medicine.drug, Adult, medicine.medical_specialty, Asia, Drug-Related Side Effects and Adverse Reactions, Fever, Population, Antineoplastic Agents, 03 medical and health sciences, Metabolic Diseases, Internal medicine, medicine, Humans, Adverse effect, education, business.industry, Antineoplastic Protocols, Imatinib, Exanthema, Hematologic Diseases, Surgery, Clinical trial, Latin America, Pyrimidines, Imatinib mesylate, Nilotinib, business, Follow-Up Studies, 030215 immunology
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68078b339f1dc0219f0e967d94164e2dTest
https://ruj.uj.edu.pl/xmlui/handle/item/94510Test -
7
المؤلفون: Philipp le Coutre, Tomasz Szczudlo, Carmino Antonio De Souza, Zhi-Xiang Shen, Ming Zheng, Saengsuree Jootar, Bayard L. Powell, Anna G. Turkina, Franck E. Nicolini, Neil Gallagher
المصدر: Cancer. 118:118-126
مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, education.field_of_study, business.industry, Population, Imatinib, Neutropenia, medicine.disease, Rash, Gastroenterology, Surgery, Imatinib mesylate, Oncology, Nilotinib, hemic and lymphatic diseases, Internal medicine, medicine, medicine.symptom, education, business, Complete Hematologic Response, Survival rate, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::2f67cc0c17f907cf2464c81bc489a9a2Test
https://doi.org/10.1002/cncr.26249Test -
8BCR-ABL positive cells and chronic myeloid leukemia in immune suppressed organ transplant recipients
المؤلفون: Philipp le Coutre, Petra Reinke, Ralf Trappe, Ruth Neuhaus, Philipp Hemmati, Marc Lalancette, Frauke Ringel, Bernd Dörken, Peter T. Daniel
المصدر: European Journal of Haematology. 84:26-33
مصطلحات موضوعية: medicine.medical_specialty, education.field_of_study, Population, Clone (cell biology), Myeloid leukemia, Chromosomal translocation, Hematology, General Medicine, Biology, Fusion protein, Organ transplantation, Immune system, hemic and lymphatic diseases, Immunology, medicine, education, Tyrosine kinase
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::f0bb272cdbcbb4f288f165422b120021Test
https://doi.org/10.1111/j.1600-0609.2009.01357.xTest -
9
المؤلفون: Iryna Dyagil, Michael J. Mauro, Valentín García Gutiérrez, Michael W. Deininger, Dragana Milojkovic, Rocco J. Crescenzo, Nathalie Bardy-Bouxin, Jorge E. Cortes, Eric Leip, Philipp le Coutre, Carlo Gambacorti-Passerini, T H Brümmendorf, Dong-Wook Kim, A. Hochhaus, Charles Chuah, Natalia Glushko
المصدر: Blood. 130:896-896
مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Immunology, Population, Newly diagnosed, Blast Phase, Biochemistry, Treatment failure, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Medicine, education, health care economics and organizations, education.field_of_study, business.industry, Imatinib, Cell Biology, Hematology, 030104 developmental biology, Imatinib mesylate, 030220 oncology & carcinogenesis, business, Bosutinib, medicine.drug, Month follow up
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::341fe42af5353a58051f528d7fa12095Test
https://doi.org/10.1182/blood.v130.suppl_1.896.896Test -
10
المؤلفون: Philipp le Coutre, Philippe Rousselot, François Guilhot, Giuseppe Saglio, Diane Healey, Tim H. Brümmendorf, Michael Cunningham, Andreas Hochhaus, Hesham Mohamed, Hagop M. Kantarjian, Jorge E. Cortes, Neil P. Shah, Charles A. Schiffer
مصطلحات موضوعية: medicine.medical_specialty, Clinical Trials and Observations, Immunology, Population, Dasatinib, Fusion Proteins, bcr-abl, Phases of clinical research, Antineoplastic Agents, Kaplan-Meier Estimate, Biochemistry, Gastroenterology, Disease-Free Survival, Piperazines, Time, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Adverse effect, education, education.field_of_study, business.industry, Myeloid leukemia, Imatinib, Cell Biology, Hematology, Discontinuation, Thiazoles, Pyrimidines, Treatment Outcome, Imatinib mesylate, Drug Resistance, Neoplasm, Benzamides, Imatinib Mesylate, business, Follow-Up Studies, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b776b6efbaae1d84b5c3b930082e1cbeTest
http://hdl.handle.net/2318/148762Test